Episode

123: Lenacapavir for HIV Prevention

Podcast
Febrile
Published
Jul 7, 2025
Duration seconds
2092
Processing state
not_requested
Canonical source
https://febrilepodcast.captivate.fm/episode/123-lenacapavir
Audio
https://episodes.captivate.fm/episode/f0cc22ed-56f4-4b3b-bce0-767f8eb9f6b8.mp3
JSON
/v1/public/podcasts/febrile-1336025/episodes/123-lenacapavir-for-hiv-prevention
Markdown
/podcast/febrile-1336025/123-lenacapavir-for-hiv-prevention.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/febrile-1336025/episodes/123-lenacapavir-for-hiv-prevention/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/febrile-1336025/123-lenacapavir-for-hiv-prevention.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Drs. Anshel Kenkare and Mike Reid share a conversation about the incredible science and current context of lenacapavir for HIV prevention, which was recently approved by the FDA. Episodes | Consult Notes | Subscribe | Twitter | Merch | [email protected] Febrile is produced with support from the Infectious Diseases Society of America (IDSA)